(lp0
S'Analyst Activity  FBR &amp; Co Reiterates Buy on BioDelivery Sciences ... Market Exclusive - 10 hours ago BioDelivery Sciences International, Inc. is a specialty pharmaceutical company. The Company develops and commercializes, either on its own or in partnerships with third parties, applications of approved therapeutics to address unmet medical needs using&nbsp;...BioDelivery  Q4 Loss Wider Than Expected; Sales Meet - Yahoo FinanceAnalyst Hints Surrounding BioDelivery Sciences International, Inc.  - Post Analyst'
p1
aS'BioDelivery Sciences International, Inc.  Files An 8-K Other Events Market Exclusive - Mar 17, 2017 BioDelivery Sciences International, Inc. is a specialty pharmaceutical company. The Company develops and commercializes, either on its own or in partnerships with third parties, applications of approved therapeutics to address unmet medical needs using&nbsp;...BioDelivery Q4 Loss Wider Than Expected; Revenues in Line - Yahoo FinanceBioDelivery Sciences International, Inc.  Posts Quarterly Earnings ... - Chaffey Breeze'
p2
aS'BioDelivery Sciences to Host Conference Call and Webcast Reporting Fourth ... PR Newswire  - Mar 9, 2017 RALEIGH, N.C., March 9, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc.  announced that it will report its fourth quarter and full-year 2016 financial results and host a conference call and webcast at 8:00 AM Eastern Time on&nbsp;...FY2017 EPS Estimates for BioDelivery Sciences International, Inc. (BDSI ... - Sports PerspectivesBioDelivery Sciences International Inc. - Receive News &amp; Ratings Daily - BBNS'
p3
aS'BioDelivery Sciences Announces the Hiring of Peter Ginsberg as Vice President ... PR Newswire  - Dec 14, 2016 RALEIGH, N.C., Dec. 14, 2016 /PRNewswire/ -- BioDelivery Sciences International, Inc.  announced that Peter Ginsberg has joined the company as Vice President of Business Development.Company Update : Why BioDelivery Sciences International, Inc ... - Smarter AnalystOn heels of Belbuca reacquisition, BDSI makes business development hire - Triangle Business Journal'
p4
aS'BioDelivery Sciences Secures Debt Financing with CRG PR Newswire  - Feb 23, 2017 RALEIGH, N.C., Feb. 23, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc.  announced today that it has entered into a senior credit facility with affiliates of CRG LP, a healthcare-focused investment firm, to retire its ...Price Target Of BioDelivery Sciences International, Inc. At $5.071 - Transcript DailyPreview of Stock Movement: BioDelivery Sciences International, Inc.  - Is stories'
p5
aS'BioDelivery Sciences Reacquires License to BELBUCA from Endo Pharmaceuticals PR Newswire  - Dec 8, 2016 RALEIGH, N.C., Dec. 8, 2016 /PRNewswire/ --BioDelivery Sciences International, Inc.  announced that it has entered into an agreement with Endo Pharmaceuticals, Inc.  terminating their licensing of rights for BELBUCA&nbsp;...BioDelivery Regains Belbuca Opioid Rights  - InvestopediaEndo Sells Back Rights for Opioid Painkiller - Wall Street Journal'
p6
aS'MonoSol Rx Files Patent Infringement Suit against BioDelivery Sciences ... GlobeNewswire  - Jan 13, 2017 ... a specialty pharmaceutical company utilizing its PharmFilm drug delivery technology to improve patient outcomes and to address unmet needs, today filed a patent infringement case against BioDelivery Sciences International, Inc. (Nasdaq:BDSI ...'
p7
aS'BioDelivery Sciences International, Inc.  Shares Open Higher on Back of ... Smarter Analyst - Sep 23, 2016 BioDelivery Sciences International, Inc.  shares are up 13% this morning, after Janney Montgomery analyst Ken Trbovich upgraded BDSI from a Neutral to a Buy rating with a price target of $4, which implies an upside of 63% from current&nbsp;...Janney Montgomery Scott Upgrades BioDelivery Sciences International  to Buy - StreetInsider.com'
p8
aS"Can BioDelivery Succeed With Belbuca? Seeking Alpha - Feb 10, 2017 BioDelivery  gave a pretty good presentation about Belbuca and the company's sales and marketing strategy going forward."
p9
aS'BioDelivery Sciences to Hold Analyst and Investor Day to Discuss BELBUCA ... PR Newswire  - Jan 26, 2017 RALEIGH, N.C., Jan. 26, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc.  will host an event for analysts and investors from 12:00 PM - 2:30 PM Eastern Time on Wednesday, February 1st, 2017, in New York City, to discuss&nbsp;...'
p10
a.